Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06870539 · ClinicalTrials.gov registry record
Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 49
- Enrollment target
NCT06870539: Completed study, sponsored by Mayo Clinic.
NCT06870539 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06870539 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
This study evaluates the feasibility and accuracy of using saliva to remotely monitor cytomegalovirus (CMV) infection in individuals receiving treatment for ovarian cancer.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2025-03-07 |
| Est. Completion | 2025-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06870539
The ClinicalTrials.gov registry entry for NCT06870539 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06870539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06870539 about?
NCT06870539 is a clinical study titled "Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment". This study evaluates the feasibility and accuracy of using saliva to remotely monitor cytomegalovirus (CMV) infection in individuals receiving treatment for ovarian cancer.
What is the current status of trial NCT06870539?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2025-03-07. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT06870539?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06870539?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.